← Back to Search

SPA-LTC Program for Frailty Syndrome

N/A

Waitlist Available

Led By Sharon Kaasalainen, PhD

Research Sponsored by McMaster University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up all residents in the home who died one year prior to the implementation and one year prior to the date of death for all residents in the home who die during the study intervention period.

Awards & highlights

Study Summary

This trial will evaluate a program to improve palliative care in long-term care, assessing its implementation and effectiveness, aiming to improve family satisfaction and staff confidence.

Who is the study for?

This trial is for English-speaking residents in long-term care who are quite frail, with a score of 50% or less on the Palliative Performance Scale. It's not suitable for those who aren't fluent in English or are less frail (score above 50%).Check my eligibility

What is being tested?

The study tests the SPA-LTC program, which aims to improve palliative care in long-term facilities. It looks at how well it works and how feasible it is across different places by measuring family satisfaction and staff knowledge.See study design

What are the potential side effects?

Since this trial focuses on implementing a care approach rather than a medical treatment, traditional side effects like you'd see with drugs aren't applicable here.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ all residents in the home who died one year prior to the implementation and one year prior to the date of death for all residents in the home who die during the study intervention period.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~all residents in the home who died one year prior to the implementation and one year prior to the date of death for all residents in the home who die during the study intervention period.

This trial's timeline: 3 weeks for screening, Varies for treatment, and all residents in the home who died one year prior to the implementation and one year prior to the date of death for all residents in the home who die during the study intervention period. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of Emergency Department Visits in the Resident's Last Year of Life

Secondary outcome measures

Bereaved Family Satisfaction with End of Life Care

Family Experiences with End of Life Care

Family Perceptions of End of Life Care

+4 more

Other outcome measures

Fidelity of the Intervention

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Within the intervention arm 9 long-term care homes will receive the SPA-LTC program:3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Group II: ControlActive Control1 Intervention

Within the control arm 9 long-term care homes will receive the standard of care: 3 in Ontario; 3 in Saskatchewan and 3 in Manitoba.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor

880 Previous Clinical Trials

2,597,234 Total Patients Enrolled

Hospice Palliative Care OntarioUNKNOWN

Canadian Hospice Palliative Care AssociationUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

At how many distinct locations is this clinical experiment being conducted?

"At the present time, this research is recruiting from 4 medical centres located in Hamilton, Regina and Saskatoon plus a further quartet of locations. To reduce travel costs to the minimal level it may be best to select the nearest site when choosing your location for participation."

Answered by AI

Are there any limitations on the number of participants for this clinical experiment?

"This medical trial necessitates 594 participants, who satisfy the established criteria and are located near McMaster University in Hamilton, Ontario or University of Regina in Saskatchewan."

Answered by AI

Is enrollment in this investigation currently available for participants?

"Affirmative. According to data on clinicaltrials.gov, this trial is actively seeking candidates. The study was first posted in June 2022 and recently updated in September 2023, with the aim of enrolling 594 patients across 4 different locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program

2022. "Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03935997.